Statewide Medicaid Expansion and Survival in Resectable Non-Small Cell Lung Cancer.

ABSTRACT:

Importance

Medicaid expansion under the Affordable Care Act broadened eligibility for government-funded health coverage. This may have improved access to early diagnosis and rapid treatment, potentially impacting survival in patients with resectable non-small cell lung cancer (NSCLC), a leading cause of cancer-related death in the US.

Objective

To evaluate the association between state-level Medicaid expansion and all-cause mortality in patients with resectable NSCLC.

Design, setting, and participants

This cohort study of patients aged 20 to 64 years who were diagnosed with stage I to IIIA NSCLC used data from the Surveillance, Epidemiology, and End Results registry collected between January 1, 2006, to December 31, 2019, with outcomes administratively censored at 2 a

SUBMITTER: Gawdi R 

PROVIDER: S-EPMC12670197 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature